I was delighted to spend a day at the FIS International 2025 conference in Bournemouth this week to collect my HIS Early Career Award. I had a the honour of an award lecture – you can download my slides here.

I was delighted to spend a day at the FIS International 2025 conference in Bournemouth this week to collect my HIS Early Career Award. I had a the honour of an award lecture – you can download my slides here.

Picked up this interesting article in Infection Prevention in Practice suggesting that contaminated toilet fixtures could be a reservoir for CPE transmission. It’s always difficult to disentangle cause and effect when it comes to surface contamination, but the study makes a compelling case that toilets were a reservoir for transmission. The solution? More cleaning and disinfection is required – but also a look at some newer approaches to bathroom disinfection, along the lines of continuous disinfection.
Intro:
Hospital environments are well-documented reservoirs for multidrug-resistant organisms. While sinks and drains have long been implicated in outbreaks, toilets have received less attention despite their potential for aerosolization during flushing. This Danish study focused on the Gastric Surgery Unit, where two ongoing CPE outbreaks were linked to Citrobacter freundii ST18 and Klebsiella oxytoca ST2, both carrying the blaNDM-1 gene. The study asked whether toilets serve as the primary source of transmission, and how genetically related are environmental and patient isolates?
Methods:
This was a longitudinal study without an intervention, tracking patient and environmental contamination on the unit. Over 450 days, the following were undertaken:
Key findings:
Limitations:
Implications for practice:
Despite the limitations, the study provides compelling evidence for the role of the inanimate environmental in the spread of CPE. So, we to:
Summary
This study underscores the potential role of toilets in the transmission dynamics of CPE. While ‘traditional’ cleaning and disinfection protocols remain essential, they may be insufficient when faced with continuous contamination in high-use areas. This feels like an area that would benefit a lot from ‘continuous disinfection’ approaches, improved bathroom design, and genomic surveillance.
A concise but powerful study has just been published in Archives of Internal Medicine, showing that the incidence of CP-CRE in clinical cultures has increased a whopping 69% between 2019 and 2023 in the USA, from 2.0 to 3.1 per 100,000 people.
Continue readingThe prevalence of CP-CRE can be eye-wateringly high in some parts of the world. In Greece, for example, the rate of carbapenem-resistance in invasive K. pneumoniae isolates was 70% in the latest EARS-Net data. In the USA, one study from a long-term acute care facility in California found that almost 50% of patients were colonised. The picture is very different in the UK, with a very low prevalence of CPE reported in most studies as illustrated by the systematic review and meta-analysis that we’re going to look at today.
Continue readingI had the pleasure of doing a talk at Infection Prevention 2023 in Liverpool today, running down the top 10 scientific articles influencing our IPC practice over the past year. You can download my slides here.
I had some trouble selecting just 10 papers from the past year, and felt a strong sense of my own bias and limitations when going through the selection process. I have my own research and clinical interests, I don’t read anywhere near as many papers as I’d like, and 10 papers really isn’t that many! Also, I tried to countdown the papers from 10 to 1 with some kind of hierarchy. After a couple of false starts here (including the most read, most controversial, best designed), I settled on the most influential in terms of challenging our thinking or modifying our practice.
So, here goes…
Continue readingI’ve had the pleasure of a few days in Geneva enjoying some fine Swiss hospitality, and fine science at ICPIC 2023. Here’s rapid reflection on scaling the risks attached to plasmid-mediated transmission of CPE, and what we can do about it (or not…!).
Continue readingNow is a really good time to focus on carbapenem-resistant bacteria. We have spent much of the past 3 years focusing on one particular virus. But now that the clinical issues linked to SARS-CoV-2 are waning for our hospital patients, the threat of carbapenem-resistance in Gram-negative bacteria comes to the fore. An excellent study with far-reaching consequences has been published from Italy. Carbapenem resistance is bad news if you have a BSI: patients with carbapenem-resistant BSI were roughly twice as likely to die as patients with carbepenem-susceptible BSI.
Continue readingA systematic review and meta-analysis identify 22 studies that used various methods to predict colonisation with antibiotic-resistant bacteria at the time of hospital admission. The models were chosen to focus on MRSA and CPO colonisation. The “performance” of these tools varied widely, with a sensitivity of 15–100% and specificity of 46–98.6% for MRSA, and sensitivity of 30–81.3% and specificity of 79.8–99.9% for CPO. I think my main take-away from this that simple risk tools for predicting colonisation with MRSA and CPO (which are often used to determine who to test) are pretty blunt instruments. However, the more advanced tools making use of big datasets and machine learning can take us forward in predicting the risk of MRSA and CPO colonisation at the time of admission.
Continue readingA helpful new study has combined shoe-leather epi and WGS to establish a transmission rate of CPE in hospitalised patients. Overall, 3 (2%) of 152 exposed patients ended up colonised with the same CPE from 47 index patient exposures. None of the 54 exposed staff ended up colonised with CPE. This transmission rate is a bit lower than I would have expected, but it’s also not zero!
Continue readingJHI have just published an interesting point prevalence HCAI and AMR study from Ukraine. Headlines are that rates of both HCAI and AMR are higher than you’d hope to see, especially with rates of resistant to carbapenems in Gram-negative bacteria and meticillin in S. aureus.
Continue reading